Gebrechliches Profil, das Standard-Dosis VRd / D-VRd Induktion in MM vorschreibt: IMWG Gebrechlichkeitspunktzahl...
Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.
| ID | RF-MM-FRAILTY-AGE |
|---|---|
| Art | Warnhinweis |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Erkrankungen | DIS-MM |
| Quellen | SRC-ESMO-MM-2023 SRC-NCCN-MM-2025 |
Ursprung der Roten Flagge
| Begriffsbestimmung | Frailty profile precluding standard-dose VRd / D-VRd induction in MM: IMWG frailty score ≥2 (defined by age ≥80 OR age 75-79 + Charlson ≥2 OR ECOG ≥2 + albumin <3.5), OR age ≥75 with ≥1 grade-2 cardiac/pulmonary comorbidity. Impacts dose schedule (Vd-Rd weekly vs twice-weekly, reduced lenalidomide, reduced dexamethasone), not regimen choice. |
|---|---|
| Klinische Richtung | Eskalation |
| Kategorie | Gebrechlichkeit |
| Schaltet Algorithmus | ALGO-MM-1L |
Logik auslösen
{
"any_of": [
{
"comparator": ">=",
"finding": "imwg_frailty_score",
"threshold": 2
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 80
}
]
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 75
},
{
"comparator": ">=",
"finding": "ecog",
"threshold": 2
},
{
"comparator": "<",
"finding": "albumin_g_dl",
"threshold": 3.5
}
]
}
],
"type": "composite_score"
}
Anmerkungen
IMWG frailty score (Palumbo 2015) is validated against survival on novel-agent regimens. Frail patients on full-dose VRd have ≈15-20% treatment-related mortality vs ≈3% on dose-modified schedules. Dose-modified VRd (V weekly, R 15-25 mg, dex 20 mg weekly) preserves efficacy with substantially better tolerability. This RF de-escalates toward IND-MM-1L-VRD with dose-modified schedule (when high-risk cytogenetics + frailty co-occur — both step 1 and this trigger fire, intensify takes precedence per direction order; engine surfaces both).
Verwendet von
Algorithmen
ALGO-MM-1L- ALGO-MM-1L
Kapitel des Handbuchs
HB-MM-1L- Multiples Myelom: First-Line-Risiko und Fitness-Realing
Anwendungsgebiet
IND-MM-ELDERLY-FRAIL-VRD-LIGHT- IND-MM-ELDERLY-FRAIL-VRD-LIGHT